Susan Pond

Q: What Schools Are Affiliated With Susan Pond

Susan Pond is affiliated with the following schools: University of Queensland, University of New South Wales, University of Sydney, University of Melbourne, University of California, San Francisco, Columbia University, Monash University

Susan Pond's AcademicInfluence.com Rankings

Susan Pond

Medical

#2522

World Rank

#2950

Historical Rank

Pharmacology

#445

World Rank

#500

Historical Rank

medical Degrees

Download Badge

Medical

Susan Pond's Degrees

Masters Pharmacology University of Melbourne
PhD Pharmacology Monash University

Why Is Susan Pond Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Susan Margaret Pond is an Australian scientist and technologist, active in business and academia, and recognised for her contributions to medicine, biotechnology, renewable energy and sustainability. She is the current president of the Royal Society of New South Wales.

(See a Problem?)

Susan Pond's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

First-Pass Elimination Basic Concepts and Clinical Consequences (1984) (388)
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. (2009) (252)
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. (1996) (231)
Gastric emptying in acute overdose: a prospective randomised controlled trial (1995) (193)
Altered methadone pharmacokinetics in methadone-maintained pregnant women. (1985) (185)
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. (1996) (138)
The Epidemiology of Parkinson’s Disease in an Australian Population (1998) (127)
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis (1997) (116)
Experience with 732 acute overdose patients admitted to an intensive care unit over six years (1993) (115)
Phenytoin-induced methadone withdrawal. (1981) (110)
Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes. (1991) (106)
Oleander interference in the digoxin radioimmunoassay in a fatal ingestion. (1982) (102)
Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. (1984) (98)
Serum formate concentrations in methanol intoxication as a criterion for hemodialysis. (1986) (98)
Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. (1996) (98)
Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease (1997) (96)
Theophylline overdose: acute single ingestion versus chronic repeated overmedication. (1985) (90)
Enhancers Are Major Targets for Murine Leukemia Virus Vector Integration (2014) (82)
Toxicologic studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos. (1983) (82)
TREATMENT OF DIGITOXIN OVERDOSE WITH ORAL ACTIVATED CHARCOAL (1981) (80)
Role of Repeated Oral Doses of Activated Charcoal in Clinical Toxicology (1986) (78)
Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol. (1991) (77)
Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulfaphenazole (1977) (76)
Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450. (1989) (68)
Failure of Haemoperfusion and Haemodialysis to Prevent Death in Paraquat Poisoning (1988) (63)
Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen. (1985) (59)
Pharmacokinetics of Drug Overdose (1981) (59)
Massive catecholamine release from caffeine poisoning. (1982) (56)
The Puzzle of Rates of Cellular Uptake of Protein-Bound Ligands (1988) (56)
The dopamine transporter gene and Parkinson's disease in a Chinese population (1997) (53)
Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia (1994) (50)
Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog. (1993) (49)
Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments. (1989) (47)
Two fatalities after acute occupational exposure to ethylene dibromide. (1984) (47)
Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model. (1991) (47)
Benefit of hemoperfusion in acute theophylline intoxication. (1984) (46)
Extracorporeal techniques in the treatment of poisoned patients (1991) (45)
Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate. (1992) (44)
Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects (1981) (44)
An assessment of the potential testicular toxicity of 10 pesticides using the mouse-sperm morphology assay. (1983) (43)
Stereospecific reduction of haloperidol in human tissues. (1992) (42)
Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem. (1997) (42)
Lack of effect of diazepam on methadone metabolism in methadone‐maintained addicts (1982) (41)
An evaluation of the effects of lithium in the treatment of chronic alcoholism. I. Clinical results. (1981) (40)
Effect of phenytoin on meperidine clearance and normeperidine formation (1981) (40)
Metabolic disposition of simvastatin in patients with T-tube drainage. (1994) (40)
Microscale high-performance liquid chromatography-electrospray tandem mass spectrometry assay for cyclosporin A in blood. (1998) (38)
Amatoxin poisoning in northern California, 1982-1983. (1986) (38)
Effects of tricyclic antidepressants on drug metabolism (1975) (37)
Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. (1982) (37)
Studies of protein interactions by biosensor technology: an alternative approach to the analysis of sensorgrams deviating from pseudo-first-order kinetic behavior. (1997) (36)
A high-performance liquid chromatography-electrospray-tandem mass spectrometry analysis of cortisol and metabolites in placental perfusate. (1997) (36)
The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose (2003) (36)
Urinary excretion of the N-acetyl cysteine conjugate of cis-1,3-dichloropropene by exposed individuals. (1984) (35)
Uptake of palmitate by hepatocyte suspensions: facilitation by albumin? (1992) (35)
Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. (1988) (34)
Amanita phalloides-type mushroom poisoning. (1982) (34)
Manifestations and management of paraquat poisoning (1990) (34)
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments. (1988) (33)
Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry. (1997) (30)
The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. (1994) (29)
Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon. (1996) (29)
A human in vivo model for the determination of lead bioavailability using stable isotope dilution. (1996) (29)
Purification and characterization of two human liver carboxylesterases. (1989) (28)
Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver. (1980) (27)
Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma. (1994) (27)
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. (1991) (27)
Quantitation of paraquat in biological samples by radioimmunoassay using a monoclonal antibody. (1992) (27)
Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship. (1991) (27)
The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man. (1975) (27)
Cortisol metabolism and its inhibition by glycyrrhetinic acid in the isolated perfused human placental lobule (1997) (26)
Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: is HPTP an intermediate? (1997) (26)
Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning. (1990) (25)
Prevention of Paraquat Toxicity in Suspensions of Alveolar Type II Cells by Paraquat-Specific Antibodies (1994) (25)
Redistribution into plasma of tracer doses of desipramine by anti-desipramine antiserum in rats. (1987) (25)
High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants. (1997) (24)
Cloning and analysis of a cDNA encoding a human liver carboxylesterase. (1991) (24)
Determination of methadone and its primary metabolite in biologic fluids using gas chromatography with nitrogen-phosphorus detection. (1981) (24)
Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in rats. (1991) (24)
Liver Damage in Nurses Handling Cytostatic Agents (1984) (22)
Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition. (1982) (22)
Management of Theophylline Overdose Patients in the Intensive Care Unit (1992) (22)
Hemoperfusion in a child who ingested diquat and died from pontine infarction and hemorrhage. (1983) (22)
Survival After Unexpected High Serum Methotrexate Concentrations in a Patient with Osteogenic Sarcoma (1990) (20)
Manual of toxicologic emergencies (1990) (20)
A technique to study hepatic and intestinal drug metabolism separately in the dog. (1982) (19)
Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin (1996) (19)
Formation of pyridinium species of haloperidol in human liver and brain (1996) (19)
Dose-dependent bioavailability and metabolism of salicylamide in dogs. (1984) (18)
Ultrastructure of canine lung during the proliferative phase of paraquat toxicity. (1988) (18)
The midbrain dopaminergic cell groups in the baboon papio ursinus (1998) (18)
Intestinal infarction complicating phenobarbital overdose. (1984) (18)
Resin hemoperfusion in ethchlorvynol overdose (1980) (17)
Lack of Efficacy of Plasmapheresis in a Patient Overdosed with Thyroxine (1994) (17)
Calibration of albumin-fatty acid binding constants measured by heptane-water partition. (1993) (17)
Clinical and Neuropathological Abnormalities in Baboons Treated with HPTP, the Tetrahydropyridine Analog of Haloperidol (1999) (17)
Prescription for poisoning (1995) (16)
Competition between paraquat and putrescine for uptake by suspensions of rat alveolar type II cells. (1992) (16)
Aging, acute oxidative injury and hepatocellular glucose transport in the rat (1995) (16)
Effects of paraquat on canine bronchoalveolar lavage fluid. (1989) (16)
Diflunisal and its conjugates in patients with renal failure. (1991) (16)
Granulomatous thyroiditis and lithium therapy. (1992) (15)
Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells (1999) (15)
Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration. (1985) (15)
Ethylesterases as indicators of liver damage. I. Studies on malathion carboxylesterases. (1982) (15)
The influence of pH on the interaction of lipophilic anthracyclines with bovine serum albumin. Quantitative characterization by measurement of fluorescence quenching. (1992) (15)
Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism (1987) (14)
Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in rats. (1991) (14)
Extracorporeal techniques in the treatment of poisoned patients: In Reply (1991) (14)
Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo. (1993) (14)
Hepatic intracellular pH during the prereplicative period following partial hepatectomy. (1993) (14)
Effects on the liver of chemicals encountered in the workplace. (1982) (14)
Evaluation and Comparison of the TDXII, Stratus, and OPUS Digoxin Assays (1995) (14)
Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen. (1982) (13)
The effects of differential induction of cytochrome P-450, carboxylesterase and glutathione S-transferase activities on malathion toxicity in mice. (1987) (13)
Severe botulism after eating home‐preserved asparagus (1992) (13)
Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma. (1996) (13)
An evaluation of the effects of lithium in the treatment of chronic alcoholism. II. Assessment of the two-period crossover design. (1981) (12)
Why Medical Toxicology? (1986) (12)
Effects of gender and pregnancy on hepatocellular uptake of palmitic acid: facilitation by albumin. (1994) (12)
Polyclonal amanitin-specific antibodies: production and cytoprotective properties in vitro. (1993) (12)
Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy Trial for the Human Immunodeficiency Virus (2009) (12)
Diazepam kinetics in acute alcohol withdrawal (1979) (11)
Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver. (1995) (11)
Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells (2000) (11)
T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals. (2012) (11)
Placebo‐Controlled, Double‐Blind Study of the Effects of Proglumide in the Treatment of Schizophrenia (1992) (11)
The importance of electrostatic interactions in the binding of paraquat to its elicited monoclonal antibody. (1990) (11)
Activated Charcoal in Phenobarbital Overdose-Reply (1985) (11)
Comparison of High‐Performance Liquid Chromatography and Monoclonal Fluorescence Polarization Immunoassay for the Determination of Whole‐Blood Cyclosporin A in Liver and Heart Transplant Patients (1994) (11)
Outbreak of Illness in a School Chorus (1983) (10)
Gas chromatographic analysis of meperidine and normeperidine: determination in blood after a single dose of meperidine. (1982) (10)
Comparison of paraquat-specific murine monoclonal antibodies produced by in vitro and in vivo immunization. (1988) (10)
Metabolic drug interactions--a critical review. (1975) (10)
Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient. (1987) (10)
Treatment of mushroom poisoning. (1984) (10)
Analysis of salicylamide and its metabolites in blood and urine by HPLC (1984) (9)
An open-label study of famotidine as a treatment for schizophrenia. (1995) (9)
Glucose transport and hypoxia–reoxygenation injury in the perfused rat liver (1994) (9)
Availability of plasma sulfate for conjugation of salicylamide in dogs. (1986) (9)
Production of a paraquat-specific murine single chain Fv fragment. (1995) (9)
Cloning, expression, and purification of an anti-desipramine single chain antibody in NS/O myeloma cells. (1995) (8)
Aging and the response of the isolated perfused rat liver to vasoactive drugs. (1992) (8)
Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia. (2000) (8)
Determination of the in vivo antigen-antibody affinity constant from the redistribution of desipramine in rats following administration of a desipramine-specific monoclonal antibody. (1991) (8)
Liver Damage Associated with Occupational Exposure to Organic Solvents in House Painters (1984) (8)
Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons. (1997) (8)
Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol (1992) (7)
Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms (1994) (7)
Extrahepatic extraction of salicylamide in dogs. (1986) (7)
Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay. (1991) (7)
The Serotonin Transporter Gene and Parkinson’s Disease (2000) (7)
Sex differences in initial clearance of palmitate by human hepatocytes (1996) (6)
Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs (1992) (6)
Removal of Theophylline From the Body by Haemoperfusion (1979) (6)
Changes in methadone pharmacokinetics during pregnancy (1982) (6)
Diltiazem Overdose in an Elderly Patient: Efficacy of Adrenaline (1992) (6)
Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol. (1996) (6)
Death from inadvertent chloroquine overdose (1994) (5)
Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamine ligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study. (1996) (5)
Hemoperfusion for Paraquat Poisoning - a Review of 42 Patients (1987) (5)
Diuresis, dialysis, and hemoperfusion. Indications and benefits. (1984) (5)
Chirality of reduced haloperidol in humans (1998) (5)
Late diagnosis of chronic salicylate intoxication (1993) (4)
Haloperidol-Derived Pyridinium Metabolites (1998) (4)
Bound Tris confounds the identification of binding site residues in a paraquat single chain antibody. (1997) (4)
Further observations on the measurement of fatty acid incorporation by erythrocyte ghosts to quantify unbound palmitate concentration in albumin-palmitate mixtures. (1996) (4)
Biliary excretion of diflunisal conjugates in patients with T-tube drainage (2004) (4)
Clinical applicability of current pharmacokinetic models: Splanchnic elimination of 5-fluorouracil in cancer patients (1988) (3)
Bioavailability and clearance of meperidine in patients with chronic liver disease (1979) (3)
Continuous Arteriovenous Hemofiltration for Paraquat Poisoning (1986) (3)
Resin hemoperfusion for ethchlorvynol. (1980) (3)
Rapid rise in serum theophylline concentration after overdose with sustained release theophylline. (1992) (3)
Impaired metabolism of methylphenobarbital after a combined drug overdose: treatment by resin hemoperfusion. (1982) (3)
Non-A, Non-B Hepatitis: A Prospective Study of a Hemodialysis Outbreak with Evaluation of a Serologic Marker in Patients and Staff (1984) (2)
Creation of a carotid-jugular fistula for repeated hemoaccess in a canine model. (1988) (2)
The effect of oxidative injury on hepatocellular influx of leucine in the rat (1996) (2)
Clostridia: An Alternative Cause of 'Ethylene Dibromide' Fatalities-Reply (1985) (2)
"Profiting" from vegetables. (1996) (2)
A review of the pharmacokinetics and efficacy of emesis, gastric lavage and single and repeated doses of charcoal in overdose patients. (1986) (2)
Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions (1984) (2)
Treatment of theophylline overdose. (1983) (2)
Granulomatous thyroiditis and lithium therapy (1992) (2)
P-2-4 Mitochondrial toxicity of haloperidol and its metabolites (1996) (1)
Interactions of Haloperidol (HP) Metabolites with transporters for Dopamine (DAT), Norepinephrine (NET) and Serotonin (SERT) (1999) (1)
ILLUMINATION OF THERAPEUTICS BY TOXICOLOGY: A PERSONAL VIEW * (1996) (1)
Concurrent determination of hepatic bioavailability of salicylamide by three techniques in the dog. (1989) (1)
Haloperidol-Derived Pyridinium Metabolites: Structural and Toxicological Relationships to MPP + -Like Neurotoxins (1997) (1)
Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition. (1988) (1)
Diflunisal andits conjugates inpatients withrenal failure (1991) (1)
Neurotoxic implications of haloperidol metabolism (1995) (0)
Non-linear hepatic first-pass metabolism of salicylamide in dogs after portacaval transposition (1988) (0)
37 LOCALISED CYCLOSPORIN CONCENTRATIONS IN CARDIAC ALLOGRAFTS (1997) (0)
61 THERAPEUTIC DRUG MONITORING OF TACROLIMUS IN WHOLE BLOOD BY HPLC/MS/MS (1995) (0)
Temperature transitions of the microsomal hydroxylation system (1977) (0)
O-2-4 Toxic haloperidol metabolites in human brain (1996) (0)
Drugged runners (and others) (1990) (0)
Efficacy of early hemoperfusion in the management of paraquat poisoning (1990) (0)
Theophylline Overdose - Reply (1992) (0)
Women face a thicket of obstacles (2014) (0)
Colchicine Overdose in 6 Patients (1993) (0)
Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs (1988) (0)
The Use of the Portacaval Transposition Technique to Study Gastrointestinal and Hepatic Metabolism of Propranolol in Dogs (1984) (0)
HIGHER HALOPERIDOL PYRIDINIUM METABOLITE LEVELS ARE ASSOCIATED WITH MOVEMENT DISORDERS IN ICU PATIENTS TREATED WITH HALOPERIDOL (1998) (0)
The Life Sciences Biotechnology Industry: Creativity in a Crisis (2009) (0)
Resin hemoperfusion in ethychlorvynol overdose. (1980) (0)
P-2-3 The quantitative analysis of a haloperidol derivative and its neurotoxic metabolites in baboons (1996) (0)
51 A RAPID HPLC-UV METHOD FOR THE ANALYSIS OF MYCOPHENOLIC ACID IN PLASMA (1997) (0)
Mechanism of inhibition of tolbutamide metabolism by phenylbutazone and oxyphenbutazone (1978) (0)
Probing hepatic function using pharmacological tools (0)
Hepatotoxicity of Trichlorethylene-Carbon Tetrachloridc Mixtures in Rats (1983) (0)

This paper list is powered by the following services:

Other Resources About Susan Pond

en.wikipedia.org

What Schools Are Affiliated With Susan Pond?

Susan Pond is affiliated with the following schools:

Susan Pond's Academic­Influence.com Rankings